Showing 4,721 - 4,740 results of 4,871 for search 'background composition (method OR methods)', query time: 0.24s Refine Results
  1. 4721
  2. 4722

    Cognitive, language and motor developmental patterns of extremely preterm children up to 2 years of age: a descriptive approach by Erika Jurišová, Lucia Ráczová, Marta Zaťková, Martina Romanová

    Published 2025-07-01
    “…BackgroundAdvancements in technology and pharmacology over the past 15 years have increased the survival rates of extremely low gestational age newborns to over 80%. …”
    Get full text
    Article
  3. 4723
  4. 4724
  5. 4725
  6. 4726
  7. 4727
  8. 4728
  9. 4729
  10. 4730
  11. 4731
  12. 4732
  13. 4733
  14. 4734

    The prevalence and the correlates of mental disorders among the elderly population: results from China Mental Health Survey by Jingjuan Pang, Minghui Li, Zhaorui Liu, Yueqin Huang, Xiaofei Hou, Guoli Yan, Xiangdong Xu, Limin Wang, Yongping Yan, Shuiyuan Xiao, Lingjiang Li, Jie Yan, Yaqin Yu, Xiufeng Xu, Zhizhong Wang, Yifeng Xu, Tao Li, Tingting Zhang, Huifang Yin, Guangming Xu

    Published 2025-08-01
    “…Abstract Background Mental disorders among the elderly are a growing public health concern contributing significantly to disease burden, disability, and mortality. …”
    Get full text
    Article
  15. 4735
  16. 4736

    Multilevel and multidimensional features of socioeconomic status and cognitive function in older adulthood: a cross-sectional analysis of the IGNITE studyResearch in context by Jermon A. Drake, Lu Wan, Chaeryon Kang, Peter J. Gianaros, Patricio Solis-Urra, Haiqing Huang, Rebecca Reed, Charles H. Hillman, Eric D. Vidoni, Jeffrey M. Burns, Arthur F. Kramer, Edward McAuley, George Grove, Kirk I. Erickson, Lauren E. Oberlin

    Published 2025-10-01
    “…Summary: Background: Lower socioeconomic status (SES) is associated with increased risk of cognitive decline and dementia, yet reliance on singular indicators of SES limits understanding of these relationships. …”
    Get full text
    Article
  17. 4737

    Associations of metabolic status with all-cause mortality among individuals with osteoarthritis: A prospective cohort study by Hao Yang, Muhui Zeng, Tianxiang Fan, Haowei Chen, Xiaofeng Fang, Zhong Alan Li, Xiaoshuai Wang, David J. Hunter, Changhai Ding, Zhaohua Zhu

    Published 2025-03-01
    “…Background: Individuals with osteoarthritis (OA) often experience significant changes in their metabolic status and have a higher risk of mortality compared to the general population. …”
    Get full text
    Article
  18. 4738

    Prediction of Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease Using Circulating Immunomodulatory Proteins by Ben Li, Farah Shaikh, Houssam Younes, Batool Abuhalimeh, Jason Chin, Khurram Rasheed, Abdelrahman Zamzam, Rawand Abdin, Mohammad Qadura

    Published 2024-12-01
    “…<b>Background/Objectives:</b> The leading cause of death for people with peripheral artery disease (PAD) is major adverse cardiovascular events (MACE), including heart attacks and strokes. …”
    Get full text
    Article
  19. 4739

    Characterizing ECOPD Phenotypes: Associations with In-Hospital Outcomes and Immunoinflammatory Mechanisms by Wang Q, Wang L, Zhang L, Zhao C, Liu Y, Liu L, Yuan L, Feng M, Wang G, Li L, Zhang S, Yuan Y, Kang D, Zhang X

    Published 2025-05-01
    “…We sought to explore the underlying mechanisms that contribute to the relationship between ECOPD phenotypes and these outcomes.Methods: A k-means cluster analysis was conducted on 20,890 recruited patients hospitalized for ECOPD. …”
    Get full text
    Article
  20. 4740

    Dual Pathway Inhibition in Patients with Atherosclerosis with or without Heart Failure: Insights from the XATOA Registry by Pishoy Gouda, MB, BCh, BAO, MSc, Justin A. Ezekowitz, MD, MSc, Alain Gay, MD, Kai Vogtländer, MSc, Victor Aboyans, MD, PhD, Sebastian Debus, MD, Keith Fox, MB, ChB, Uwe Zeymer, MD, Robert Welsh, MD

    Published 2025-04-01
    “…Background: Patients with atherosclerotic cardiovascular disease might benefit from dual pathway inhibition (DPI) therapy, which includes rivaroxaban and aspirin. …”
    Get full text
    Article